Key result
Surgical LAA closure linked to ~68% fewer 1-year thromboembolic events versus no closure.
Why the study?
Whether the benefits of interventional left atrial appendage closure in reducing thromboembolic events can be fully translated to surgical LAA closure in patients with AF undergoing cardiac surgery was unclear and data were lacking.
Does surgical left atrial appendage closure reduce thromboembolic events and death in patients with permanent atrial fibrillation undergoing cardiac surgery?
Observational (n=398)
Does surgical left atrial appendage closure reduce thromboembolic events and death in patients with permanent atrial fibrillation undergoing cardiac surgery?
Absolute Event Rate: 6.6% vs 20.5%
p-value: p=<0.01
Surgical left atrial appendage closure during cardiac surgery in patients with permanent atrial fibrillation is associated with significantly reduced thromboembolic events and improved 1-year survival.
May support surgical LAA closure during cardiac surgery; hypothesis-generating pending randomized confirmation.
OBJECTIVE: Most of the detected thrombi in patients with atrial fibrillation (AF) can be found in the left atrial appendage (LAA). Interventional LAA closure recently proved to be noninferior to warfarin therapy. Whether these results can be fully translated into surgical LAA closure remains unclear. Corresponding data are still lacking. The present observational study evaluated the impact of surgical LAA closure in patients with AF undergoing cardiac surgery on postoperative thromboembolic events. METHODS: A prospective registry enrolled 398 patients with permanent AF undergoing cardiac surgery. Concomitant procedures were isolated surgical ablation (group I, n = 71), isolated LAA closure (group II, n = 44), and combined surgical ablation and LAA closure (group III, n = 196). The control group consisted of 87 patients without concomitant surgical ablation or LAA closure. One-year follow-up was completed in all patients. End points were thromboembolic events and death from any cause. RESULTS: Clinical baseline characteristics were comparable among the groups. General hospital mortality was 5.5% and likewise differed not significantly. Postoperatively, mean (SD) CHAD2S2-VASc score of 3.5 (1.3) differed not significantly among the groups, indicating comparable thromboembolic risk. Follow-up referred to all hospital survivors (n = 376). Herein, overall incidence of thromboembolic events was 9.8% (n = 37), with an associated mortality of 41.0%. Patients with LAA closure alone or in combination with surgical ablation had a significantly reduced incidence of thromboembolic events (6.6% vs 20.5%, P < 0.01) and consecutively improved survival after 1 year of follow-up (7.0% vs 17.1%, P < 0.01). CONCLUSIONS: Left atrial appendage closure alone or in combination with surgical ablation was associated with a significantly reduced rate of thromboembolic events and consecutively improved survival after 1 year of follow-up.
No takes yet. Share an insight, caveat, or question.
Wilbring et al. (2016) conducted an observational in Permanent atrial fibrillation (n=398). Surgical left atrial appendage closure (alone or with surgical ablation) vs. No concomitant surgical ablation or left atrial appendage closure was evaluated on Thromboembolic events (p=<0.01). Surgical left atrial appendage closure during cardiac surgery significantly reduced the incidence of thromboembolic events compared to no closure (6.6% vs 20.5%, P<0.01) at 1 year of follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: